Customization: | Available |
---|---|
Powder: | Powder |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Name | Ozagrel |
Purity | 99% |
Origin | China |
Application | Research |
Character | Powder |
Appearance | White Powder |
Mr Gray and clopidogrel, helo he thiazole, aspirin enteric-coated metformin hydrochloride is at present, the commonly used platelet aggregation inhibitor, belongs to the coagulation evil alkyl epoxy enzymes (TXA2) inhibitors antithrombotic drugs, initially by Japanese ono pharmaceutical industry co., LTD and Kissei pharmaceutical industry research and development success, approed for sale in Japan in 1988. At present, the main domestic manufacturers are Liaoning Dandong Medical innovation pharmaceutical co., LTD., Shandong Luo Xin Pharmaceutical Co., LTD., Changchun Jingyou Pharmaceutical Co., LTD., Dalian Meruo Pharmaceutical Co., LTD., Shenyang Cheshi Pharmaceutical Co., LTD., Hainan Biicalbook Kai Pharmaceutical Co., LTD., Changchun Haobang Pharmaceutical Co., Ltd. and Shandong Hualu Pharmaceutical Co., LTD. Modern medicine has proved that platelets play an important role in the process of arteriosclerosis and thrombosis, and effective regulation of platelets can get twice the result with half the effort for diseases caused by vascular lumen stenosis, blood embolus and circulatory system occlusion. At present, the main platelet agglutination inhibitors in clinical use are cytase (TXA2) inhibitors, phosphodiesterase (PDE) inhibitors, adenosine diphosphate (ADP) receptor blockers, platelet fibrinogen blockers and other drugs.